EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Development and validation of MonteRay, a fast Monte Carlo dose engine for carbon ion beam radiotherapy

Peter Lysakovski, Benedikt Kopp, Thomas Tessonnier, Stewart Mein, Alfredo Ferrari, Thomas Haberer, Jürgen Debus, Andrea Mairani

Medical Physics · 2024-02 · 51 (2) · 1433-1449

DOI: 10.1002/mp.16754 ↗

At a glance

Journal article in Medical Physics, published online on 2023-09-25. Written by Peter Lysakovski and 7 co-authors. Institution: Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. Major MEDLINE topics: Heavy Ion Radiotherapy, Proton Therapy. Cited 21 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: German Federal Ministry of Education and Research (BMBF).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Monte Carlo (MC) simulations are considered the gold‐standard for accuracy in radiotherapy dose calculation; so far however, no commercial treatment planning system (TPS) provides a fast MC for supporting clinical practice in carbon ion therapy.

Purpose

To extend and validate the in‐house developed fast MC dose engine MonteRay for carbon ion therapy, including physical and biological dose calculation.

Methods

MonteRay is a CPU MC dose calculation engine written in C++ that is capable of simulating therapeutic proton, helium and carbon ion beams. In this work, development steps taken to include carbon ions in MonteRay are presented. Dose distributions computed with MonteRay are evaluated using a comprehensive validation dataset, including various measurements (pristine Bragg peaks, spread out Bragg peaks in water and behind an anthropomorphic phantom) and simulations of a patient plan. The latter includes both physical and biological dose comparisons. Runtimes of MonteRay were evaluated against those of FLUKA MC on a standard benchmark problem.

Results

Dosimetric comparisons between MonteRay and measurements demonstrated good agreement. In terms of pristine Bragg peaks, mean errors between simulated and measured integral depth dose distributions were between −2.3% and +2.7%. Comparing SOBPs at 5, 12.5 and 20 cm depth, mean absolute relative dose differences were 0.9%, 0.7% and 1.6% respectively. Comparison against measurements behind an anthropomorphic head phantom revealed mean absolute dose differences of with global 3%/3 mm 3D‐γ passing rates of 99.3%, comparable to those previously reached with FLUKA (98.9%). Comparisons against dose predictions computed with the clinical treatment planning tool RayStation 11B for a meningioma patient plan revealed excellent local 1%/1 mm 3D‐γ passing rates of 98% for physical and 94% for biological dose. In terms of runtime, MonteRay achieved speedups against reference FLUKA simulations ranging from 14× to 72×, depending on the beam's energy and the step size chosen.

Conclusions

Validations against clinical dosimetric measurements in homogeneous and heterogeneous scenarios and clinical TPS calculations have proven the validity of the physical models implemented in MonteRay. To conclude, MonteRay is viable as a fast secondary MC engine for supporting clinical practice in proton, helium and carbon ion radiotherapy.

Subjects

MeSH terms (MEDLINE)

Heavy Ion RadiotherapyProton TherapyHumansProtonsRadiotherapy DosageHeliumRadiotherapy Planning, Computer-AssistedMonte Carlo MethodCarbon

Author keywords

carbon ionsdose calculationfast Monte Carloradiotherapy

Substances

ProtonsHeliumCarbon

Authors and institutions

  • Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, Germany.
  • Clinical Cooperation Unit Translational Radiation Oncology, German Cancer Consortium (DKTK) Core-Center Heidelberg, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Resea…
  • Division of Molecular and Translational Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Heidelberg, Germany.
  • Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University Hospital (UKHD), Heidelberg Faculty of Medicine (MFHD) and German Cancer Research Center (DKFZ), He…
  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

  • German Federal Ministry of Education and Research (BMBF)

Cite

APA

Lysakovski, P., Kopp, B., Tessonnier, T., Mein, S., Ferrari, A., Haberer, T., Debus, J., & Mairani, A. (2024). Development and validation of MonteRay, a fast Monte Carlo dose engine for carbon ion beam radiotherapy. Medical Physics, 51(2), 1433-1449. https://doi.org/10.1002/mp.16754

Vancouver

Lysakovski P, Kopp B, Tessonnier T, Mein S, Ferrari A, Haberer T, et al. Development and validation of MonteRay, a fast Monte Carlo dose engine for carbon ion beam radiotherapy. Medical Physics. 2024;51(2):1433-1449. doi:10.1002/mp.16754

BibTeX
@article{Lysakovski2024,
  author = {Lysakovski, Peter and Kopp, Benedikt and Tessonnier, Thomas and Mein, Stewart and Ferrari, Alfredo and Haberer, Thomas and Debus, Jürgen and Mairani, Andrea},
  title = {Development and validation of MonteRay, a fast Monte Carlo dose engine for carbon ion beam radiotherapy},
  journal = {Medical Physics},
  year = {2024},
  volume = {51},
  number = {2},
  pages = {1433--1449},
  doi = {10.1002/mp.16754}
}
Start for free →